While company data showed a slight drop in efficacy against any symptomatic cases of covid-19, from 96 percent protection in the first two months following vaccination to 84 percent after four months, the vaccine was 97 percent effective against severe disease.
Pfizer data shows vaccine protection remains robust six months after vaccination even as the company argues that boosters will be needed
